乳房切除术后患者无复发生存与死亡率的比较分析:来自数十年、多机构倾向评分匹配的见解
该回顾性图表综述纳入1979至2019年在纽约长老会系统2家机构接受乳房切除术的患者,采用倾向评分匹配、 logistic回归、非配对t检验和卡方检验分析。结果显示总体癌症复发率为6.62%(317例),总体死亡率为16.8%(803例);在复发患者中,完成重建序列与更早发现癌症复发及改善生存几率相关(P < 0.05);仅重建组的分层分析显示,接受游离皮瓣手术的患者有死亡获益(P < 0.05)。
要点
- 总体癌症复发率为6.62%(317例),总体死亡率为16.8%(803例)。
- 复发患者中,完成重建序列与更早发现复发及改善生存几率相关(P < 0.05)。
- 仅重建组分层分析显示,游离皮瓣手术患者有死亡获益(P < 0.05)。
核心结论
- 乳房切除术后接受乳房重建的患者可能更好地获得随访护理并改善与医疗系统的对接,这可能提高癌症复发的检出速度。
- 本研究强调需要一致的整形外科转诊以及乳腺癌护理团队所有成员对癌症复发的持续监测。
研究设计与样本
- 回顾性图表综述,收集1979至2019年在纽约长老会系统2家机构接受乳房切除术的患者数据。
- 记录社会人口学信息、病史和治疗方式,采用倾向评分匹配、logistic回归、非配对t检验和卡方检验进行统计分析。
主要发现
- 总体癌症复发率为6.62%(317例),总体死亡率为16.8%(803例)。
- 对于复发患者,完成重建序列与更早发现癌症复发及改善生存几率相关(P < 0.05)。
- 仅重建组的分层分析显示,接受游离皮瓣手术的患者有死亡获益(P < 0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Disparities in postmastectomy reconstructive care are widely acknowledged. However, there is limited understanding regarding the impact of reconstructive services on cancer recurrence and breast cancer-related mortality. Therefore, this study aims to examine how patient-specific factors and breast reconstruction status influence recurrence-free survival and mortality rates in breast cancer patients. METHODS: Retrospective chart review was performed to collect data on patients who underwent mastectomy at 2 institutions within the New York-Presbyterian system from 1979 to 2019. Sociodemographic information, medical history, and the treatment approach were recorded. Propensity score matching, logistic regression, unpaired t test, and chi-square test were used for statistical analysis. RESULTS: Overall, cancer recurrence occurred in 6.62% (317) of patients, with 16.8% (803) overall mortality rate. For patients who had relapsed disease, completion of the reconstruction sequence was correlated with an earlier detection of cancer recurrence and improved survival odds (P < 0.05). Stratified analysis of the reconstruction group alone showed mortality benefit among patients who underwent free flap procedures (P < 0.05). CONCLUSION: Patients undergoing breast reconstruction after mastectomy are likely to have better access to follow-up care and improved interfacing with the healthcare system. This may increase the speed at which cancer recurrence is detected. This study highlights the need for consistent plastic surgery referral and continued monitoring by all members of the breast cancer care team for cancer recurrence among patients.
引用
- Chen Y, Alston C, Chadab TM, et al. Comparative Analysis of Recurrence-Free Survival and Mortality in Postmastectomy Patients: Insights From Multidecade, Multiinstitutional Propensity Score Matching. Ann Plast Surg. 2024. PMID: 38556657. doi:10.1097/SAP.0000000000003858
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。